期刊文献+

Mesenchymal stem cells as a potential therapeutic tool to cure cognitive impairment caused by neuroinflammation 被引量:1

下载PDF
导出
摘要 An established contribution of neuroinflammation to multiple brain pathologies has raised the requirement for therapeutic strategies to overcome it in order to prevent age-and disease-dependent cognitive decline.Mesenchymal stem cells(MSCs)produce multiple growth and neurotrophic factors and seem to evade immune rejection due to low expression of major histocompatibility complex class I molecules.Therefore,MSCs are widely used in experiments and clinical trials of regenerative medicine.This review summarizes recent data concerning the optimization of MSC use for therapeutic purposes with the emphasis on the achievements of the last 2 years.Specific attention is paid to extracellular vesicles secreted by MSCs and to the role ofα7 nicotinic acetylcholine receptors.The reviewed data demonstrate that MSCs have a significant therapeutic potential in treating neuroinflammation-related cognitive disfunctions including age-related neurodegenerative diseases.The novel data demonstrate that maximal therapeutic effect is being achieved when MSCs penetrate the brain and produce their stimulating factors in situ.Consequently,therapeutic application using MSCs should include measures to facilitate their homing to the brain,support the survival in the brain microenvironment,and stimulate the production of neurotrophic and anti-inflammatory factors.These measures include but are not limited to genetic modification of MSCs and pre-conditioning before transplantation.
作者 Maryna Skok
出处 《World Journal of Stem Cells》 SCIE 2021年第8期1072-1083,共12页 世界干细胞杂志(英文版)(电子版)
  • 引文网络
  • 相关文献

参考文献4

二级参考文献123

  • 1Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405(6785):458-462.
  • 2Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421 (6921):384-388.
  • 3Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21(3): 383-421.
  • 4Connelly CA, Chen LC, Colquhoun SD. Metabolic activity of cultured rat brainstem, hippocampal and spinal cord slices. J Neurosci Methods. 2000;99(1-2):1-7.
  • 5Salawu FK, Umar JT, Olokoba AB. Alzheimer's disease: a review of recent developments. Ann Afr Med. 2011 ;10(2): 73-79.
  • 6Balasingam V, Tejada-Berges T, Wright E, et al. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci. 1994;14(2):846-856.
  • 7Newhouse PA, Ielton M. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond. Pharm Acta Helv. 2000;74(2-3):91-101.
  • 8O'Neill M J, Murray TK, Lakics V, et al. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr Drug Targets CNS Neurol Disord. 2002;1(4):399-411.
  • 9Graham A, Court JA, Martin-Ruiz CM, et al. Immunohistochemical Iocalisation of nicotinic acetylcholine receptor subunits in human cerebellum. Neuroscience. 2002;113(3):493-507.
  • 10Mccarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol. 1980;85(3):890-902.

共引文献26

同被引文献6

引证文献1

;
使用帮助 返回顶部